ALAM
Asahi Life Asset Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,345
| Closed | -$321K | – | 164 |
|
|
2025
Q1 | $321K | Buy |
2,345
+60
| +3% | +$8.21K | 0.21% | 135 |
|
|
2024
Q4 | $349K | Buy |
2,285
+485
| +27% | +$74.2K | 0.21% | 112 |
|
|
2024
Q3 | $349K | Buy |
+1,800
| New | +$349K | 0.21% | 133 |
|
|
2024
Q2 | – | Sell |
-1,660
| Closed | -$358K | – | 155 |
|
|
2024
Q1 | $358K | Buy |
+1,660
| New | +$358K | 0.21% | 117 |
|
|
2023
Q2 | – | Sell |
-1,310
| Closed | -$364K | – | 191 |
|
|
2023
Q1 | $364K | Sell |
1,310
-15
| -1% | -$4.17K | 0.12% | 105 |
|
|
2022
Q4 | $367K | Sell |
1,325
-515
| -28% | -$143K | 0.12% | 103 |
|
|
2022
Q3 | $491K | Buy |
1,840
+10
| +0.5% | +$2.67K | 0.15% | 64 |
|
|
2022
Q2 | $373K | Buy |
+1,830
| New | +$373K | 0.1% | 82 |
|
|
2021
Q1 | – | Sell |
-2,140
| Closed | -$524K | – | 199 |
|
|
2020
Q4 | $524K | Buy |
2,140
+300
| +16% | +$73.5K | 0.07% | 103 |
|
|
2020
Q3 | $522K | Buy |
1,840
+790
| +75% | +$224K | 0.08% | 70 |
|
|
2020
Q2 | $281K | Buy |
+1,050
| New | +$281K | 0.05% | 135 |
|
|
2020
Q1 | – | Sell |
-1,840
| Closed | -$546K | – | 195 |
|
|
2019
Q4 | $546K | Sell |
1,840
-260
| -12% | -$77.2K | 0.08% | 77 |
|
|
2019
Q3 | $489K | Buy |
2,100
+10
| +0.5% | +$2.33K | 0.08% | 70 |
|
|
2019
Q2 | $489K | Buy |
+2,090
| New | +$489K | 0.1% | 75 |
|